Top news
All coverage
Pfizer, BioNTech submit emergency authorization request to FDA Friday for COVID-19 vaccine
By Morgan Winsor
How Much Will A Covid-19 Vaccine Cost?
By Katie Jennings
We may have to accept a 'good enough' COVID-19 vaccine, at least in 2021
By Ross Upshur, Paul A. Komesaroff & Ian Kerridge
New Pfizer results show its COVID-19 vaccine is nearly 95% effective
By Tina Hesman Saey
Breakthrough COVID vaccine tech could help defeat other diseases
By John Miller & Ludwig Burger
Why the Most Promising Covid-19 Vaccines Require Super-Cold Storage
By Theresa Machemer
Moderna and Pfizer Are Reinventing Vaccines, Starting With Covid
By Peter Loftus, Jared S. Hopkins & Bojan Pancevski
Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy
By Matthew Herper & Damian Garde
Pfizer to seek Covid-19 vaccine approval 'within days' as trial shows 95 percent efficacy
By Erika Edwards & Alexander Smith
Covid-19 vaccines could be available by the end of December. Here's what needs to happen first.
By Erika Edwards
Covid vaccine: Pfizer says '94% effective in over-65s'
By Naomi Grimley
November 20 coronavirus news
By Adam Renton, Helen Regan & Sebastian Shukla
BioNTech and Pfizer will seek emergency US authorization for vaccine on Friday, CEO says
By Zamira Rahim & Frederik Pleitgen
Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns
By Amanda Sealy & Maggie Fox
Pfizer and BioNTech request emergency authorization from FDA for Covid vaccine
By Berkeley Lovelace & Berkeley Lovelace Jr.
Pfizer says final data analysis shows Covid vaccine is 95% effective, plans to submit to FDA in days
By Berkeley Lovelace & Berkeley Lovelace Jr.
Covid vaccine front-runners: How much they cost, who's bought them and how they're stored
By Sam Meredith
Why Moderna And Pfizer Vaccines Have Different Cold Storage Requirements : Shots - Health News
By Selena Simmons-Duffin